Treatment plan comparison using equivalent uniform biologically effective dose (EUBED).

With the continuing improvement in computer speed, dose distributions can be calculated quickly with confidence. However, the resulting biological effect is known with much less certainty, despite its critical importance when assessing treatment plans. To assess plans accurately, biologically based methods of ranking plans are necessary. Many authors have suggested the use of dose volume histograms with reduction schemes and Niemierko has recently introduced another method based on the cell kill occurring in the tumour. This study presents an investigation into this value and suggests a use in prescribing dose. Equivalent uniform dose (EUD) can obviously be used for assessing treatment plans, although in its current form it is not adequate for assessing normal tissues; however, it can also be used to adjust the prescription dose ensuring all plans deliver the same EUD to the tumour. Once this is performed, plans can more easily be assessed on the effects to the normal tissues. In calculating the EUD another concept is introduced--the equivalent uniform biologically effective dose (EUBED). This value considers the distribution of dose and dose per fraction when comparing plans. Reduced dose per fraction at the edge of the target volume will exacerbate the effect of reduced dose on cell kill. Two methods are suggested for calculating the necessary prescription dose: one using an iterative method and one using the gradient of the EUBED function. A comparison was made for a series of stereotactic cases using different collimator sizes. Interestingly, using this method, although the maximum doses were different, the dose volume histograms (DVHs) for the brainstem were similar in all cases.

[1]  T E Schultheiss,et al.  Models in radiotherapy: volume effects. , 1983, Medical physics.

[2]  A practical evaluation of five dose-volume histogram reduction algorithms. , 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[3]  T E Schultheiss,et al.  Models in radiotherapy: definition of decision criteria. , 1985, Medical physics.

[4]  R Mohan,et al.  A feasibility study of automated inverse treatment planning for cancer of the prostate. , 1998, International journal of radiation oncology, biology, physics.

[5]  A Brahme,et al.  Tumour and normal tissue responses to fractionated non-uniform dose delivery. , 1992, International journal of radiation biology.

[6]  L. Gras,et al.  Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 GY) conformal radiotherapy for prostate cancer, using dose-volume histograms. , 1998, International journal of radiation oncology, biology, physics.

[7]  A. Niemierko Reporting and analyzing dose distributions: a concept of equivalent uniform dose. , 1997, Medical physics.

[8]  M T Munley,et al.  Physical and biological predictors of changes in whole-lung function following thoracic irradiation. , 1997, International journal of radiation oncology, biology, physics.

[9]  A B Wolbarst,et al.  Optimization of radiation therapy, IV: A dose-volume histogram reduction algorithm. , 1989, International journal of radiation oncology, biology, physics.

[10]  G. Barendsen,et al.  Dose fractionation, dose rate and iso-effect relationships for normal tissue responses. , 1982, International journal of radiation oncology, biology, physics.

[11]  Simon Kramer,et al.  The relationship of dose to infield failure for stages A, B and C prostate cancer. An analysis of 1516 patients , 1987 .

[12]  B. Clark,et al.  Modeling late effects in hypofractionated stereotactic radiotherapy. , 1999, International journal of radiation oncology, biology, physics.

[13]  J H Hendry,et al.  A realistic closed-form radiobiological model of clinical tumor-control data incorporating intertumor heterogeneity. , 1998, International journal of radiation oncology, biology, physics.

[14]  A. Barrett,et al.  The linear-quadratic transformation of dose-volume histograms in fractionated radiotherapy. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[15]  R. Lane,et al.  A test of the claim that plan rankings are determined by relative complication and tumor-control probabilities. , 1998, International journal of radiation oncology, biology, physics.

[16]  P. Hoban,et al.  Some characteristics of tumour control probability for heterogeneous tumours. , 1996, Physics in medicine and biology.

[17]  A B Wolbarst,et al.  Optimization of radiation therapy, III: A method of assessing complication probabilities from dose-volume histograms. , 1987, International journal of radiation oncology, biology, physics.

[18]  C. Burman,et al.  Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method. , 1989, International journal of radiation oncology, biology, physics.